PR - QuadraMed Announces Share Repurchase Program

Reston, Va.-based QuadraMed Corporation (Amex: QD) today announced that its Board of Directors has authorized a program to repurchase, with available cash, up to $5 million of the Company’s common stock. The Company anticipates that the repurchase program will begin immediately and will continue for up to four months.

The repurchase program is to be conducted in accordance with Rule 10b5-1 and Rule 10b-18 under the Securities Exchange Act of 1934. The company intends to repurchase its common stock from shareholders through registered broker-dealers in open market purchase transactions and plans to hold any shares repurchased as treasury shares. The company plans to use the repurchased shares for any purpose that its Board of Directors determines to be advisable in accordance with applicable law.

The company believes that the share repurchase program is advisable at this time, and is in the best interests of the company and its shareholders, in light of the current trading price of the company’s common stock and the general market and economic conditions affecting the company.

QuadraMed is an information technology and revenue cycle management provider to hospitals and other healthcare providers in the United States.